Abstract
Altered expression of peripheral myelin protein 22 (PMP22) results in demyelinating peripheral neuropathy. PMP22 exhibits a highly restricted tissue distribution with marked expression in the myelinating Schwann cells of peripheral nerves. Auditory and vestibular Schwann cells and the afferent neurons also express PMP22, suggesting a unique role in hearing and balancing. Indeed, neuropathic patients diagnosed with PMP22-linked hereditary neuropathies often present with auditory and balance deficits, an understudied clinical complication. To investigate the mechanism by which abnormal expression of PMP22 may cause auditory and vestibular deficits, we studied gene-targeted PMP22-null mice. PMP22-null mice exhibit an unsteady gait, have difficulty maintaining balance, and live for only ∼3–5 weeks relative to unaffected littermates. Histological analysis of the inner ear revealed reduced auditory and vestibular afferent nerve myelination and profound Na+ channel redistribution without PMP22. Yet, Na+ current density was unaltered, in stark contrast to increased K+ current density. Atypical postsynaptic densities and a range of neuronal abnormalities in the organ of Corti were also identified. Analyses of auditory brainstem responses (ABRs) and vestibular sensory-evoked potential (VsEP) revealed that PMP22-null mice had auditory and vestibular hypofunction. These results demonstrate that PMP22 is required for hearing and balance, and the protein is indispensable for the formation and maintenance of myelin in the peripheral arm of the eighth nerve. Our findings indicate that myelin abnormalities and altered signal propagation in the peripheral arm of the auditory nerve are likely causes of auditory deficits in patients with PMP22-linked neuropathies.
Significance Statement
Hearing loss and vestibular hypofunction are the most common sensory disorders. Patients diagnosed with PMP22-linked neuropathies, such as Charcot–Marie–Tooth (CMT) disease, often have the initial presentation in auditory and balance deficits. Using the PMP22-null mouse model, we show that the auditory and vestibular hypofunction ensues from auditory and vestibular neuron demyelination and Na channel abnormalities.
Introduction
Hereditary peripheral neuropathies (HPNs) represent a heterogeneous group of neurological disorders characterized by proprioceptive sensory loss, ataxia, muscle weakness, and postural instability (Wilmshurst and Ouvrier, 2011). It is generally considered a peripheral neuropathy of the lower extremities, although rare trigeminal neuropathy and facial palsy case reports are indicated (Coffey and Fromm, 1991). Clinical studies also show loss of sound segregation, hearing, and vestibular impairment are constant presentations in the disease progression (Kovach et al., 2002) and, at times, the first chief complaint (Seeman et al., 2004). Demyelination of the eighth nerve in HPNs, including Charcot–Marie–Tooth diseases (CMTs), has been reported in some cases (Starr et al., 2003; Rance et al., 2012; Poretti et al., 2013), but in others it was less remarkable relative to the norm. The underlying mechanisms for the auditory and vestibular hypofunction in CMTs are unknown, albeit early presentations (Seeman et al., 2004). However, traces of the auditory and balance deficit may help in diagnosis and potential early intervention.
The eighth nerve subserves the gateway for the sound–balance–brain interface in the inner ear. It houses the cochlea and vestibular end organs, comprising hair cells (HCs) that encode sound, gravity, and head acceleration information by transducing mechanical stimuli into neural codes in action potentials (APs) of afferent neurons to the brain (Hudspeth, 1989). Approximately 90% of the auditory neurons (type I afferent neurons) are bipolar neurons, extending myelinated unbranched peripheral projections to inner hair cells (IHCs; Zhang and Coate, 2017) and central axons to the brain. Schwann cells seed myelin on the peripheral neurites, and oligodendrocytes myelinate the central axons. A transition zone between Schwann cells and oligodendrocyte-derived myelin has been identified (Toesca, 1996). At the axon initial segment (AIS), which is classically a dendrite for primary auditory neurons, there is a noncanonical zone called heminode (Liberman, 1980) that extends ∼30 µm from the IHC–auditory nerve (AN) synapse and serves as the AP initiation site (Hossain et al., 2005; Kim and Rutherford, 2016). Similar AP-initiating zones have been identified in vestibular afferent neurons (VANs; Chimento et al., 1994). The heminodes and nodes of Ranvier are decorated with Na+ channel clusters (Colbert and Pan, 2002; Hossain et al., 2005; Kim and Rutherford, 2016) to mediate AP initiation and saltatory propagation, ensuring swift acoustic and vestibular conduction (Huxley and Stampfli, 1949; Ritchie and Rogart, 1977; Browne et al., 2017). The distinct separation of the myelination machinery of auditory and vestibular neurons makes them ideal models for studying disease mechanisms with differential central and peripheral segments, as in peripheral neuropathies.
The PMP22 gene encodes a 22 kDa glycoprotein and is expressed primarily by myelinated Schwann cells. PMP22 constitutes a critical component of peripheral nerve myelin, underpinned by multiple HPNs stemming from the allele's overexpression, deletion, and point mutations. Indeed, PMP22-linked neuropathies account for ∼70% of HPNs (DiVincenzo et al., 2014). PMP22-linked neuropathies are classified as type 1 HPNs, with the primary lesion being demyelination, but axonopathy and distal neurodegeneration frequently accompany the disease. In humans, the autosomal dominantly inherited CMT1A is most frequently associated with duplication of the intact PMP22 gene (Szigeti and Lupski, 2009). In a smaller group of CMT type 1E patients, single amino acid substitutions in PMP22 have been reported (Huang et al., 2013). Haploinsufficiency of PMP22 causes hereditary neuropathy with pressure palsy (HNPP) and compression-induced neuropathy (Attarian et al., 2020). The varied symptoms and presentations abound in auditory and vestibular hypofunction in CMT patients. In some clinical settings, profound hearing loss is seen early (Seeman et al., 2004); in others, it is progressive with no known mechanisms (Kovach et al., 2002; Giuliani et al., 2019). Although PMP22-linked monogenic human neuropathies are clear, the protein's function is not fully understood. To begin to investigate the underlying mechanism for the inner ear pathobiology of PMP22-linked disorders, we examined PMP22-deficient, complete knock-out (KO) mice, whereby the coding exons are replaced with the β-galactosidase reporter gene (Amici et al., 2006).
We report that the null deletion of PMP22 results in profound auditory and vestibular hypofunction, with the hard-of-hearing features encompassing hidden hearing loss (HHL) and hearing loss (HL; Sergeyenko et al., 2013; Liberman, 2015). The balancing threshold to linear acceleration is severely compromised in PMP22−/− mice. The profound demyelination of the peripheral branch of the eighth nerve, Na+ channel clusters redistribution, but not Na+ current density, and increased K+ current density subserve the mechanisms for the observed auditory and vestibular deficits.
Materials and Methods
PMP22-deficient LacZ Mice
All procedures were performed under research guidelines of the Institutional Animal Care and Use Committee of the University of Nevada, Reno. Mice of either sex were studied using similar numbers. Transgenic PMP22-deficient LacZ mice were generated using the VelociGene targeting technology (Valenzuela et al., 2003), as previously reported (Amici et al., 2006). Heterozygous PMP22-deficient mice on the 129S1/SclmJ background were bred to generate PMP22+/+, PMP22+/−, and PMP22−/− pups. Genotype was determined by PCR using genomic DNA isolated from tail biopsies (Lee et al., 2014). All experiments in this study were done with 3–4-week-old littermates.
ABR and distortion product otoacoustic emission measurements
PMP22 mice (PMP22+/+, PMP22+/−, and PMP22−/−) littermates were tested at 3–4 weeks of age. Mice were anesthetized using ketamine (40 mg/kg) and xylazine (10 mg/kg) intraperitoneal injection. The body temperature was monitored using a rectal probe and maintained at 36.8 ± 1.0°C with a homeothermic device (Harvard Apparatus). ABR and distortion product otoacoustic emission (DPOAE) measurements were described previously (Dou et al., 2004). For ABR assays, thresholds were obtained by presenting tone bursts at 4, 8, 16, and 32 kHz and a clicking sound from 0 to 90 dB sound pressure levels (SPL) in 5 dB intervals. Tones were 2.5 ms, while click was 0.1 ms in duration, with a repetition rate of 21/s. Electrodes were placed subdermally behind the tested ear (reference), the vertex (active), and the back (ground). Evoked potentials were averaged over 512 repetitions and collected using a Tucker-Davis Technologies (TDT) RZ6 processor and BioSigRZ software. The threshold was defined as the lowest intensity of stimulation that yielded a repeatable waveform based on an identifiable ABR wave. To compensate for the base-to-apex sound propagation through the cochlea (von Bekesy, 1970) and accurately estimate auditory processing delays, we examined the latency between peaks I and II of the ABR using chirp sound stimulus (3–80 kHz, 3.5 ms duration; Benichoux et al., 2018).
DPOAE measurements were performed using the same TDT system with two calibrated MF1 speakers connected to an ER10B + microphone. Data was collected every 21 ms and averaged 512 times. DPOAEs were recorded using two pure tones with frequencies f1 and f2, using an f2/f1 ratio 1.2. Input/output (I/O) functions were obtained by increasing the primary tone L1 (and corresponding L2) in 5 dB steps from 20 to 80 dB SPL at 8, 16, and 32 kHz frequencies. During DPOAE testing, the probe assembly was placed in the mouse's left ear canal after visual inspection to ensure no ear infection or inflammation of the tympanic membrane. DPOAE thresholds were defined as the lowest level of f1 required to produce a DPOAE greater than −5 dB SPL (Chen et al., 2021).
VsEP measurement
Mice were anesthetized using ketamine (40 mg/kg) and xylazine (10 mg/kg), and VsEP recordings were made, as described (Jones et al., 1999). The skull was stabilized with a head mount. Stimuli were linear acceleration pulses of 2 ms duration, nine pulses per second, presented in standard and inverted directions. Normal polarity was defined as the upward displacement of the shaker platform while inverted in the downward platform displacement. Stimulus amplitude was measured in jerk (da/dt, i.e., g/ms, where 1.0 g = 9.8 m/s2 and 1.0 g/ms = 9.8 µm/ms) using a calibrated accelerometer attached to the shaker platform. Stimulus amplitude ranged from −18 to +6 dB re 1.0 g/ms, adjusted in 3 dB steps. Two-channel signal averaging was used to resolve vestibular responses from background electroencephalographic activity. The electrophysiological activity was amplified (200,000×) and filtered (300 to 3,000 Hz), and VsEPs were recorded to normal and inverted stimulus polarities (1,024 points, 10 µs per point, 128 responses per averaged waveform). Three response parameters were quantified: threshold, peak latencies, and peak-to-peak amplitudes. The threshold is measured in dB re 1.0 g/ms and is defined as the stimulus amplitude midway between that which produced a discernible VsEP and that which failed to produce a response. The threshold measures the sensitivity of the gravity receptor end organs, utricle, and saccule. Thresholds, latencies, and amplitudes were averaged for each group and analyzed.
Inner ear histological analyses of hair cells and synaptic counts
The cochlea was microdissected into three to four pieces, as described (Montgomery and Cox, 2016). Cochlear pieces were measured, and a frequency map was computed based on a 3D reconstruction of the sensory epithelium for HCs and synapse count of associated structures to relevant frequency regions using a custom plug-in to ImageJ (Muniak et al., 2013). Confocal z-stacks of the 4, 8, 16, and 32 kHz areas were collected using a Leica Stellaris 8 (Leica) and Nikon A1R laser scanning confocal microscope (Nikon Instruments). Images were gathered in a 1,024 × 1,024 raster using a high-resolution oil immersion objective (60× and 100×). IHCs at the frequency locations were quantified using myosin-VIIa–positive as an HC marker within a 70–100 μm field (Chen et al., 2021). Synaptic ribbons and postsynaptic markers could be counted manually using 3D (x–y–z axis) representations of each confocal z-stack with the microscopic image analysis software Imaris (Oxford Instruments).
The cochleae were intra-labyrinthine perfused through the oval and round windows with 4% paraformaldehyde (PFA) in phosphate-buffered saline (PBS). The samples were decalcified in 10% ethylenediaminetetraacetic acid (EDTA) in PBS for up to 48 h at 4°C. Microdissected pieces were immunostained with antibodies to the following: (1) mouse anti-C-terminal binding protein 2 (presynaptic marker, BD Biosciences, 1:200); (2) rabbit anti-myosin VIIa (HC marker, Proteus Biosciences, 1:600); (3) rabbit anti-Homer 1 (postsynaptic marker, Synaptic Systems, 1:250); (4) rabbit anti-Tuj1 (BioLegend, 1:500), chicken anti-Tuj1 (Abcam,1:500), and mouse anti-Tuj1 (Abcam, 1:500); (5) rabbit anti-PMP22 (Abcam, 1:500); (6) chicken anti-MBP (EnCor Biotechnology, 1:500), rabbit anti-MBP (Abcam, 1:500), mouse IgG2b anti-MBP (Abcam, 1:500); (7) chicken anti-MPZ (Abcam, 1:500); (8) goat anti-calretinin (Swant, 1:500); (9) mouse anti-calretinin (MilliporeSigma, 1:200); and (10) rabbit anti-calbindin (Cell Signaling Technology, 1:200) with appropriate secondary antibodies coupled to Alexa 405, 488, 568, and 647 fluorophores from Jackson ImmunoResearch and Thermo Fisher Scientific. DAPI labeled the cell nucleus after secondary antibody incubation. Samples were stained with phalloidin and mounted with Fluoro-Gel (Electron Microscopy Sciences). Images were captured under a confocal microscope.
Electron microscopy
Cochlear sensory epithelia transmission electron microscopy (TEM) was performed as described previously (Nie et al., 2005). Three-week-old PMP22-null mice and the littermates were killed, and the cochleae were fixed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer at 4°C overnight. After several washes with buffer alone, the cochleae were fixed in 1% osmium tetroxide at room temperature (RT) for 1 h. After that, the fixed cochleae were decalcified in 10% EDTA for 3–4 d. Fixed and decalcified cochleae were dehydrated using a graded ethanol series and embedded in epoxy resin. Ultrathin sections were cut with a diamond knife. Specimens were examined using an electron microscope as described (Nie et al., 2005).
Electrophysiology
Spiral ganglion neurons (SGNs) were isolated from the mice's (PMP22+/+ and PMP22−/−) inner ear using a combination of enzymatic and mechanical procedures (Lv et al., 2012). Male and female (3 weeks) mice were killed, and the temporal bones were removed and incubated in a solution containing Minimum Essential Medium with HBSS (Invitrogen), 0.2 g/L kynurenic acid, 10 mM MgCl2, 2% fetal bovine serum (FBS; v/v), and glucose (6 g/L). As previously described, the SGN tissue was dissected and split into apical and basal segments across the modiolar axis (Lv et al., 2010). The tissues were digested separately in an enzyme mixture containing collagenase type I (1 mg/ml) and DNase (1 mg/ml) in a water bath with a vibration rate of 70/min at 37°C for 15 min. After a series of gentle trituration in a centrifugation solution containing Minimum Essential Medium with HBSS, 0.2 g/L kynurenic acid, 10 mM MgCls, 10% PBS, and glucose (6 g/L), the cell pellets were reconstituted in 500 μl of culture media [Neurobasal-A, supplemented with 2% B27 (v/v), 0.5 mM L-glutamine, 100 U/ml penicillin; Invitrogen]. The sample was filtered through a 40 μm cell strainer for additional cell culture and electrophysiological experiments. We cultured SGNs for ∼48–72 h to allow the detachment of Schwann cells from neuronal membrane surfaces.
For membrane voltage measurements in SGNs, the extracellular solution for most experiments contained the following (in mM): 145 NaCl, 6 KCl, 1 MgCl2, 0–2 CaCl2, 10 D-glucose, and 10 HEPES, at pH 7.3. For perforated patch experiments, the tips of the pipettes were filled with the internal solution containing the following (in mM): 150 KCl, 10 HEPES, and 10 D-glucose at pH 7.3. The pipettes were front-filled with the internal solution and back-filled with a similar solution containing 250 μg/ml amphotericin and 2 mM Ca2+. For current measurements in SGNs, recordings were obtained using the whole-cell configuration of the patch-clamp technique. Signals were amplified using an Axopatch 200B (Molecular Devices) amplifier and filtered (bandpass 2–10 kHz). Data was digitized using an analog-to-digital converter (Digidata 1322; Molecular Devices). Patch electrodes were pulled from borosilicate glass capillaries with a Flaming/Brown microelectrode puller (P97, Sutter Instrument) and fire-polished to a final resistance of ∼2–3 MΩ. The SGNs were then filled with the following internal solution in mM: 112 KCl, 2 MgCl2, 0.1 CaCl2, 5 MgATP, 0.5 Na2GTP, 1 EGTA or 10 BAPTA, and 10 HEPES, pH 7.35, with KOH. The external solution consisted of (in mM) 130 NaCl (or 5 NaCl and 125 NMGCl), 5 KCl, 1 MgCl2, 1 CaCl2, 10 D-glucose, and 10 HEPES, pH 7.4, with NaOH. The bath solution was constantly perfused at 1–2 ml/min. The liquid junction potentials were measured and adjusted as described (Rodriguez-Contreras and Yamoah, 2001). All recordings were obtained at RT (20–22°C).
Data analyses
Data were analyzed using pClamp10.2 (Molecular Devices) and Origin8.1 (MicroCal software). All measurements were presented as mean ± SD, and Student's test was used to determine statistical significance (p < 0.05). Analyses of voltage- and current-clamp data followed that described in previous reports (Lv et al., 2010, 2012; Levic et al., 2011).
Results
Auditory and vestibular deficits after null deletion of PMP22
Results from assessment of PMP22 expression in wild-type mice (PMP22+/+) inner ear revealed robust expression on the eighth nerve fibers of the auditory and vestibular systems (Fig. 1). The PMP22-null mutant's (PMP22−/−) eighth nerve were not only devoid of PMP22 expression but other myelin protein, for example, myelin basic protein (MBP), was often missing and when seen, was in atypical patchy clusters. We hypothesized that PMP22 is required for the eighth nerve myelination and expected its null deletion to alter the speed of auditory (sound) and balancing conduction and processing. Analyses of the absolute hearing threshold in response to clicking and pure tone chirps (4, 8, 16, and 32 kHz) showed a significant increase in sound levels (Fig. 2A). However, assessment of outer hair cell (OHC) functions by DPOAE detected no difference between the wild-type and the mutant mice (Fig. 2B,C). Results from the PMP22−/− mice had a striking resemblance to demyelination-mediated features of HHL (Liberman, 2015; Wan and Corfas, 2017). The sound conduction speed was monitored in ABR waves I and II latencies, reflecting IHC-to-SGN activity between PMP22+/+ and PMP22−/− mice. The significant latencies recorded from click-sound–elicited waveforms among the two genotypes suggested conduction delay (Fig. 2D). We used chirp-sound–triggered ABR to account for the base-to-apex traveling wave delay. Chirp-sound–evoked waves I and II also yielded response latencies in keeping with the conduction delay (Fig. 2E).
The VAN sensitivity was assessed using linear VsEP measurements. Linear VsEPs are compound APs of the vestibular portion of the eighth nerve and its central relays (Jones and Jones, 1999; Jones et al., 2002; Zhao et al., 2008). They are generated by the utricle and saccule in response to linear jerk stimuli, with calyx-bearing afferents providing the most robust response. Profound deficits were evident in linear VsEPs recorded from PMP22−/−, relative to age-matched PMP22+/+ mice (Fig. 3). The PMP22−/− mice had higher thresholds and delayed response peaks. The peak latencies of waves I and II were used for statistical analyses. Responses recorded from the left and right sides were similar, so the right side was chosen for study. Figure 3 shows the mean latencies as a function of stimulus intensities for −12 to 6 dB re 1 g/ms.
Expression of myelin proteins in PMP22-null mutants
Myelin is a lipid-rich, multilamellar insulator of nerve fibers, with critical proteins underlying the molecular architecture of this specialized membrane (Arroyo and Scherer, 2000). Deletion of PMP22 could potentially disrupt the overall structure and prevent the formation of compact myelin (Amici et al., 2006). Therefore, we examined the expression of myelin protein zero (MPZ) and MBP in auditory and vestibular nerves in the inner ear of PMP22+/+ and PMP22−/− littermates (Fig. 4). There was a robust expression of MPZ and MBP around nerve fibers in PMP22+/+ cochlea and vestibule (Figs. 4, 5). In contrast, in the PMP22−/− mice, the distribution of MBP and MPZ was irregular and concentrated around a few fibers. A similar patchy expression of MPZ and MBP was observed around the cell bodies of VANs.
Ultrastructural analyses revealed the nodal region of the spiral laminaris in PMP22+/+ mice of the eighth nerve fiber is encased by myelin produced by the Schwann cell, with only a few macrophages present (Fig. 6). In contrast, the norm for the PMP22-null cochlea was the loss of myelinated nerve fibers, and when present, thin myelin surrounded only a few fibers (Fig. 6). Meanwhile, the diameter of the PMP22−/− auditory nerve fibers relative to controls appeared unaffected, despite the lack of myelin (Fig. 6C,D). Schwann cell numbers were diminished in the PMP22−/− cochlea, while the macrophage numbers increased with phagocytotic activity. In the PMP22+/+ mice, the nodal region of the eighth nerve fiber shows paranodal myelin loops adjacent to the node (Fig. 6E). Schwann cell microvilli cover the node, while a thin layer of the cytoplasm covers the myelin lamellae. The presence of myelin sheath in a PMP22−/− cochlea was unusual, with a collapsed appearance and no evidence of lamellae. Numerous small areas with lucent space consistent with myelin breakdown products were noted within the myelin sheath, ensheathed by myelin with a prominent tomacula, and sites of axonal myelin breakdown were apparent.
Redistribution of Na+ channels and current density in PMP22-null mutant nerves
Clustered Na+ channels regulate the generation and propagation of APs at the AIS and at axonal nodes, to promote AP saltatory conduction. Because these sites are defined by myelin distribution, the disruption of myelin in the PMP22−/− nerve fibers raise the possibility that Na+ channels partitioning along auditory nerve fibers may be altered. The heminode (Liberman, 1980) is also a specialized segment of the auditory nerve decorated with increased Na+ channel density to serve as the AP initiating site (Hossain et al., 2005; Kim and Rutherford, 2016) for the forward-propagation of APs. In keeping with the typical Na+ channel expression, we observed clusters at the heminodes in PMP22+/+ mice. Contrasting results were seen in PMP22−/− mice, where Na+ channels were expressed in a nonclustered and disorganized fashion along the nerve fiber (Fig. 7A,B). At the node of Ranvier, Na+ channels were distinctly clustered in PMP22+/+ mice.
To examine the functional significance of Na+ channel redistribution and altered myelination on membrane properties in SGNs, we performed current-clamp recordings and studied membrane currents that may shape the AP profiles. The resting membrane potentials (Vrest) appeared similar in SGNs from both genotypes [PMP22+/+ = −62 ± 6 mV (n = 37); PMP22−/− = −58 ± 8 mV (n = 29)]. SGNs isolated from PMP22+/+ mice required less current injection (0.10 ± 0.05 nA; n = 28) to evoke an AP compared with SGNs from PMP22−/− mice (0.15 ± 0.07 nA; n = 25; Fig. 8A). Comparatively, AP elicited in PMP22+/+ had a lower threshold than PMP22−/− SGNs. Similar Vrest and threshold voltage trends were obtained for SGNs that produced two or more APs upon current injection (Fig. 8B). Generally, PMP22−/− SGNs were less excitable relative to PMP22+/+ with ∼30% shift toward 1-AP-elicited neuron (Fig. 8C).
To investigate the underlying mechanisms for the decreased membrane excitability in PMP22−/− SGNs, we performed whole-cell recordings on SGNs isolated from 3-week-old littermates. In the voltage-clamp configuration, when outward currents were suppressed with pipette Cs+, NMG+, and bath TEA, and inward Ca2+ currents curbed with bath-Ca2+ (0.1 mM), whole-cell currents revealed a transient inward current, mediated by voltage-dependent inward (Na+) current, that activated approximately −40 mV and peaked at approximately −20 mV. When activated with an instantaneous current-voltage protocol, the current reversed at 48 ± 4 (n = 7) and 51 ± 6 mV (n = 7) for the PMP22+/+ and PMP22−/− SGNs, respectively. A summary of the current densities in the wild-type and mutant mice showed no quantitative differences (Fig. 8D). Because the observed membrane responses between the two genotypes could also be attributed to outward current alterations, we targeted outward K+ currents. Similarly, as described previously, inward currents were blocked to evaluate the magnitude of the whole-cell K+ currents. We identified a stark contrast between whole-cell outward K+ current amplitudes in SGNs of the PMP22−/− mice and their age-matched PMP22+/+ controls (Fig. 8E), particularly in 1-AP elicited neurons. The precise identity of the K+ channel subtype/s altered in the SGNs would require future studies beyond the scope of the present report.
The observed shift in membrane excitability in the PMP22−/− SGNs (Fig. 8C) raised the possibility of SGN subtype (Shrestha et al., 2018; Sun et al., 2018) alterations. No significant restructuring of neuronal subtypes was identified using calbindin, calretinin, and pou4f1 as markers for SGNs and VANs (Fig. 9). SGNs can show delayed loss after earlier loss of synaptic contacts to the IHCs. We examined the synaptic connections between the IHCs and SGNs at two tonotopic locations [4–8 (apex) and 32–45 (base) kHz] and found no observable qualitative differences between PMP22+/+ and PMP22−/− mice in the organization of afferent synapses, identified as paired CtBP2 (red) and Homer1 (green) immunopuncta (Fig. 10C,D). Quantifying the mean number of synapses per IHC indicated no statistically significant differences between PMP22+/+ and PMP22−/− mice when comparing tonotopic regions (Fig. 10B; p values = 0.9543 for apex and 0.8315 for base; ordinary one-way ANOVA with Sidak's correction for multiple comparisons). Thus, despite differences in the ABR wave I responses between the studied genotypes, which mimicked HHL in the PMP22−/− mice, there were no indications of changes in pre- and postsynaptic numbers in the cochleae of PMP22−/− mice. However, morphological changes in the postsynaptic marker volume in the PMP22−/− mice (Fig. 10E) implicate synaptopathy as a contributory factor in the documented HHL and HL.
Discussion
The auditory and vestibular systems process the fastest time-limiting sensory codes and the swiftest human reflex (Huterer and Cullen, 2002). Among the essentials for speed is nonquantal neurotransmission in the calyceal synapse between vestibular HCs and first-order neurons (Eatock, 2018). A recently identified phenomenon wherein primary auditory neurons are directly, mechanically sensitive at the non-myelinated synaptic terminals may also shape the speed of auditory temporal coding (Perez-Flores et al., 2022). The peripheral dendrites of the eighth nerve, which subserve the sound–balance–brain interphase, are furnished with compact myelin at the internodes to reduce membrane capacitance and facilitate AP speed propagation. Major protein constituents of compact myelin are MPZ, MBP, and PMP22. Although PMP22 comprises ∼2–5% of the total proteins in myelin, its functional importance is underpinned by mutations of the PMP22 allele that result in common forms of CMTs, a disease with an estimated prevalence of one in 2,500 people (Skre, 1974). The typical and dominant symptoms of CMT neuropathies are characteristic slowed nerve conduction velocity and diminished amplitudes of motor and sensory responses of the extremities (Dyck and Lambert, 1968). However, the condition is marked by expanding phenotypic heterogeneity, including hearing loss and balance defects being some of the early features of the disease (Seeman et al., 2004; Rance et al., 2012; Estilow et al., 2019). The near-instant reactiveness of the auditory and vestibular systems to stimuli makes them serve as gateways to sensory-deficit–prone diseases.
The objectives of the present study were to analyze the auditory and vestibular phenotype of PMP22-deficient mice to investigate the physiological functions of PMP22 in vivo. The homozygous mutant mice did not express detectable PMP22 protein, confirming the effectiveness of the null mutation strategy (Valenzuela et al., 2003). Homozygous mutants were born in the standard Mendelian ratio but exhibited excess mortality (mean live span ∼3–5 weeks), demonstrating that PMP22 is not essential for embryonic development but is required for survival after birth. Severe ataxia was evident after 2 weeks, and analyses of linear vestibular and auditory functions revealed balance deficit and hearing loss. Because the peripheral aspects of the eighth nerve myelination are conferred by Schwann cells, and PMP22 is a principal functional constituent of compact myelin (Amici et al., 2006), we considered the likelihood that the ataxia and hearing loss might emanate from the inner ear. It is conceivable that a component of the sensory and motor disorders at the lower extremities and cerebellar dysfunction may contribute to the ataxia phenotype but not the auditory system. Here, we focused on the inner ear abnormalities.
The sense of balance and equilibrium are detected by the vestibular end organs, namely, the utricle and saccule, which sense changes in linear acceleration and head position relative to gravity, and the semicircular canals, which detect changes in angular acceleration. The hair cells in epithelia detect the motion, and the myelinated afferent neurons establish giant calyceal and bouton synapses (Eatock, 2018) to convey neural codes to the brain. The neural signals are the difference in the discharge of the firing rate of vestibular afferents, modulating the tonic firing rate on both sides in opposite directions. Surface preparation and histological assessment of the three end organs of PMP22−/− mice did not reveal any abnormalities, nor did the gelatinous cupula within the ampulla of each duct and the otolithic membrane overlying the sensory epithelia. However, PMP22-null mutants’ afferents lacked compact myelin, and the expression of myelin proteins was sparse. A similar lack of compact myelin formation has been seen in the sciatic nerve of young mutant mice (Amici et al., 2006), supporting a role for PMP22 in postnatal nerve development. The fact that the null mutants exhibited difficulties maintaining their balance at a standstill and in motion and delayed VsEP, is consistent with a deficit in vestibular afferent AP discharge. Thus, the lack of myelin provides a striking histopathological correlation of the defect in balance.
Other striking observations were the hearing deficits and the histopathology of the auditory nerve fibers in PMP22-null mice. ABR measurements using click and chirp sound, accounting for sound traveling waves along the cochlear frequency axis, showed PMP22−/− mice had severe HHL, and threshold assessment revealed profound hard-of-hearing. Notably, the PMP22 transcript is known to be expressed in the human fetal cochlea (Robertson et al., 1994). Loss of auditory fibers, absence of compact myelin, lack of defined nodes of Ranvier, and subsequent loss of nodal Na+ channel clusters and heminodal Na+ channels, are abnormalities that likely curtail AP initiation and propagation, resulting in ABR and VsEP waves I and II latencies. The observed unaltered Na+ current densities in the PMP22-null mutants relative to the PMP22+/+, at least in the cell bodies of auditory and vestibular neurons, suggest that Nav expression and membrane trafficking remain intact, but the channel localization mechanisms may be warped in the absence of PMP22. In contrast, neuronal demyelination diseases have been shown to increase K+ current (Ng et al., 2008), which is consistent with the present findings, although the exact mechanism remains unclear.
Schwann cells may be the recognized primary hub for PMP22 synthesis, but the protein expression has a sensory neuronal component regulating the signaling pathways in myelination (Maier et al., 2002, 2003). Sensory neurons with distinct regulatory elements to endorse the cross talk between their upstream promoters and Schwann cells may constitute important myelination components and subserve PMP22 mutation and disease pathology. Additionally, PMP22 may not be a mere component of the myelin protein complex but an important molecule for early neural development (Parmantier et al., 1997; Wulf et al., 1999). The severe disease phenotype and rare occurrence of neuropathic patients with PMP22-null genotypes argue for a broader role for PMP22 beyond myelin synthesis. Indeed, a case report of a severely affected PMP22-null boy described predominantly large fiber sensory loss, with decreased proprioception and sensory ataxia (Saporta et al., 2011). Sensorineural hearing impairment, with progression beyond presbyacusis, has also been reported in patients with heterozygous deletion of the PMP22 gene (Verhagen et al., 2005). While the current study did not include heterozygous PMP22-deficient mice, the described morphological and electrophysiological data provide novel insights into the requirement of PMP22 in the inner ear. Future studies will examine how other disease-linked PMP22 mutations impact auditory and vestibular systems.
Footnotes
The project was supported by grants from the National Institutes of Health (P01 AG051443, DC015135, DC016099, DC015252, and R01 AG060504) to E.N.Y, and the Facial Pain Research Foundation to L.N. This work was also made possible by the imaging services provided by the High Spatial and Temporal Resolution Imaging Core of the COBRE for Molecular and Cellular Signal Transduction in the Cardiovascular System, supported by a grant from the National Institute of General Medical Sciences (P20GM130459) and the National Institutes of Health. The mouse model used for these studies has been provided as a gift by Regeneron Pharmaceuticals.
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.